
Osteoarthritis (OA) is a complex joint disorder in which inherited susceptibility intersects with immune and metabolic processes. We integrated gut-microbiota, 731 immune-cell-trait and 1,400 plasma-metabolite genome-wide association study summary statistics with an OA genome-wide association study (n = 403,124) using two-sample Mendelian randomization. All screening analyses are reported with false-discovery-rate (FDR) control, and nominal findings are framed as exploratory. Associations passing prespecified sensitivity filters underwent colocalization, summary-data-based Mendelian randomization with the HEIDI test using blood cis-eQTLs, and expression assessment in a merged 43-sample cartilage resource. Screening identified 8 microbial taxa, 39 immune traits and 97 metabolites or ratios at nominal significance; no exposure–OA association survived FDR correction. Two associations, the glycine-to-serine ratio and CD45RA on TD CD8br, replicated at Bonferroni significance in FinnGen (61,356 cases, 315,115 controls) with concordant effect sizes, whereas neither colocalization signal reproduced. In the discovery analysis, colocalization provided moderate support for a shared signal between a long-chain sphingomyelin trait (GCST90200134) and OA at SPTLC3 (PP.H4 = 0.82; stable for p12 ≥ 1 × 10⁻5 but lower under the most conservative prior), whereas the signal between a CD8 T-cell phenotype and OA at DHX16 was weak (PP.H4 = 0.49) and depended on the analysis window. Integration of SNP-annotated and SMR-prioritized genes yielded 92 candidates; 60 were assessable in cartilage; six showed nominal expression differences and one (TBC1D17) survived FDR correction. Together, the results provide a hypothesis-generating prioritization of one moderate colocalization signal and cartilage-expressed candidate genes, requiring validation in tissue-specific experimental systems.
The efficacy of effective microorganism products in aquaculture covers multiple aspects that act directly on fish, such as improving resistance to fungal, bacterial, and viral infections, reproduction, feed efficiency, and overall growth performance, or indirectly through improved water quality. In this study, the application of two commercial water and two commercial food Effective Microorganism supplements was tested under recirculating aquaculture system conditions for their effect on the water and intestinal microbiome of common carp (Cyprinus carpio), as well as on carp growth performance. Neither the dynamics of alpha diversity nor the abundance of single genera followed a pattern related to the experimental setup defined by the supplementation. However, the effects of supplementation were clearly manifested by an increase in the final weight of the fish. The most consistent alteration was a significant increase in Lactococcus abundance in the intestinal microbiome compared to that in the control group, as observed in both experimental setups. We conclude that feed supplementation with Lactococcus enhances its intestinal abundance in fish and promotes improved growth performance, likely through mechanisms involving glucose absorption and metabolism, as demonstrated in previous studies.
GM1 gangliosidosis is a rare, autosomal recessive, progressive, neurosomatic lysosomal storage disorder caused by GLB1 gene variants. The disease demonstrates significant phenotypic heterogeneity, with poor genotype-phenotype correlation. We describe a familial case series of five affected siblings presenting with a variable spectrum of disease manifestations. Clinical evaluation was performed in all siblings, whereas biochemical investigations and neuroimaging were performed in the proband and next-generation testing was performed in two severely affected sibling. Variant interpretation was carried out using standard American College of Medical Genetics and Genomics (ACMG) criteria and phenotype based re-annotation tool. Genetic testing identified compound heterozygous GLB1 variants - c.1325G > A and c.326G > C, confirming the diagnosis of GM1 gangliosidosis. Although the age of onset was similar (6–7 years) in most siblings, variability was observed in disease severity, neurological manifestations and progression. This series highlights the importance of molecular diagnosis in children presenting with unexplained neuroregression. Early genetic confirmation facilitates appropriate genetic counselling, supportive care and prenatal diagnosis.
Bovine mastitis is a complex inflammatory disease. Somatic cell count and bacteriological culture are central to bovine mastitis diagnosis. Complementary molecular measurements could clarify processes underlying persistent mammary injury. Circular RNAs (circRNAs) are relatively stable, back-spliced transcripts with context-dependent expression and potential regulatory functions, making them relevant candidates for investigating post-transcriptional control in the bovine mammary gland. This review critically evaluates circRNA evidence in bovine mastitis, with particular emphasis on Staphylococcus aureus and Escherichia coli. It integrates findings from mammary epithelial-cell models, mammary tissue and animal studies, peripheral blood, milk extracellular vesicles and N⁶-methyladenosine-associated circRNA profiling. Available studies report changes in circRNA abundance and modification patterns under mastitis-associated conditions. Candidate circRNAs are associated with inflammatory signalling, epithelial organization, vesicle and phagosome biology, and apoptosis. One functional study also implicates a circRNA in ferroptosis. However, most reported circRNAs are supported only by differential expression, expression validation, host-gene enrichment or predicted circRNA–microRNA–mRNA networks. These findings identify candidate mechanisms but do not establish direct regulation. Functional evidence remains limited, although circPRIM2 and circ_HOMER3 demonstrate that individual circRNAs can modify inflammatory, secretory, apoptotic and ferroptotic phenotypes in bovine mammary epithelial-cell models. Milk extracellular vesicle circRNAs are analytically detectable and infection responsive, but diagnostic sensitivity, pathogen discrimination and added value beyond established tests remain unproven. Progress now depends on coordinate-based nomenclature, full-length isoform resolution, direct interaction and rescue experiments, pathogen-defined animal studies and independent longitudinal cohorts. The immediate priority is therefore to move beyond circRNA catalogues and identify a smaller set of reproducible candidates with validated mechanisms and measurable translational value.
PRSS57 encodes neutrophil serine protease 4 (NSP4), a granule-associated protease involved in myeloid cell biology and innate immunity. Clinical evidence has associated high PRSS57 expression with failure to achieve early molecular response in chronic myeloid leukemia (CML) during tyrosine kinase inhibitor (TKI) therapy. However, treatment-associated regulation of PRSS57 remains poorly characterized. K562 cells were treated with imatinib, nilotinib, or dasatinib, and 48-h IC₅₀ values were determined by MTT assay. PRSS57 mRNA expression was assessed by RT-qPCR at 24, 48, and 72 h using the respective 48-h IC₅₀ concentrations. HL60, NB4, and THP-1 cells were treated with 1 µM all-trans retinoic acid (ATRA) and analyzed at the same time points. All three TKIs significantly increased PRSS57 mRNA expression in K562 cells at 24 h, with expression remaining elevated at 48 h and declining toward baseline by 72 h. Dasatinib showed the largest and most sustained increase. In acute myeloid leukemia (AML) models, ATRA produced limited and variable changes in HL60 and NB4 cells, whereas THP-1 cells showed robust and sustained PRSS57 upregulation from 24 to 72 h. PRSS57 expression is dynamically regulated in a treatment- and cell-type-dependent manner in myeloid leukemia models. These findings support further investigation of PRSS57 at the protein and functional levels.